Jacobs Levy Equity Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-245,018
| Closed | -$1.3M | – | 1147 |
|
|
2021
Q2 | $1.3M | Buy |
245,018
+130,579
| +114% | +$691K | 0.01% | 693 |
|
|
2021
Q1 | $532K | Hold |
114,439
| – | – | ﹤0.01% | 858 |
|
|
2020
Q4 | $378K | Buy |
+114,439
| New | +$378K | ﹤0.01% | 887 |
|
|
2018
Q2 | – | Sell |
-12,400
| Closed | -$108K | – | 1124 |
|
|
2018
Q1 | $108K | Buy |
+12,400
| New | +$108K | ﹤0.01% | 967 |
|